Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Receptors, Androgen × Genitourinary × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

High Risk Prostate Cancer 1

Interventions

Magnetic Resonance Spectroscopy 89 Specimen Handling 72 pembrolizumab 66 enzalutamide 51 Radiosurgery 49 Radiotherapy 44 Docetaxel 44 Androgen Antagonists 41 Gemcitabine 40 Nivolumab 33 darolutamide 32 Cisplatin 32 Carboplatin 30 Abiraterone Acetate 30 Prednisone 29 Pluvicto 28 Biopsy 28 cabozantinib 25 Standard of Care 25 apalutamide 24 Blood Specimen Collection 24 enfortumab vedotin 22 Radiation 22 abiraterone 18 Leuprolide 18 Ipilimumab 18 Surveys and Questionnaires 17 gallium 68 PSMA-11 16 X-Rays 16 relugolix 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06758882 2025-01-06

STAPLE

A.O.U. Città della Salute e della Scienza

Phase 2 Recruiting

High Risk Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡